Cardiometabolic Risk, Peripheral Arterial Disease and Cardiovascular Events in Polycystic Ovary Syndrome: Time to Implement Systematic Screening and Update the Management.

Janez, Andrej; Herman, Rok; Poredos, Pavel; Mikhailidis, Dimitri P; Blinc, Ales; Sabovic, Miso; Studen, Katica Bajuk; Jezovnik, Mateja Kaja; Schernthaner, Gerit-Holger; Anagnostis, Panagiotis; Antignani, Pier Luigi; Jensterle, Mojca

Janez, Andrej; Herman, Rok; Poredos, Pavel; Mikhailidis, Dimitri P; Blinc, Ales; Sabovic, Miso; Studen, Katica Bajuk; Jezovnik, Mateja Kaja; Schernthaner, Gerit-Holger; Anagnostis, Panagiotis; Antignani, Pier Luigi; Jensterle, Mojca.

Afiliación

Janez A; Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Herman R; Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Poredos P; Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Mikhailidis DP; Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Blinc A; Department of Vascular Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Sabovic M; Division of Surgery and Interventional Science, Department of Surgical Biotechnology, University College London Medical School, University College London (UCL), UK.
Studen KB; Department of Clinical Biochemistry, Royal Free Hospital Campus (UCL), London, UK.
Jezovnik MK; Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Schernthaner GH; Department of Vascular Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Anagnostis P; Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Antignani PL; Department of Vascular Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Jensterle M; Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Curr Vasc Pharmacol ; 21(6): 424-432, 2023.

Article en En | MEDLINE | ID: mdl-37779406

Asunto(s)

Aterosclerosis; Enfermedades Cardiovasculares; Hiperandrogenismo; Resistencia a la Insulina; Enfermedad Arterial Periférica; Síndrome del Ovario Poliquístico; Femenino; Humanos; Síndrome del Ovario Poliquístico/complicaciones; Síndrome del Ovario Poliquístico/diagnóstico; Síndrome del Ovario Poliquístico/epidemiología; Enfermedades Cardiovasculares/diagnóstico; Enfermedades Cardiovasculares/epidemiología; Enfermedades Cardiovasculares/etiología; Enfermedad Arterial Periférica/diagnóstico; Enfermedad Arterial Periférica/epidemiología; Enfermedad Arterial Periférica/terapia; Factores de Riesgo

Palabras clave

Polycystic ovary syndrome; atherosclerosis; cardiometabolic risk.; cardiovascular events; cardiovascular risk; peripheral arterial disease

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome del Ovario Poliquístico / Resistencia a la Insulina / Enfermedades Cardiovasculares / Hiperandrogenismo / Aterosclerosis / Enfermedad Arterial Periférica Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans Idioma: En Revista: Curr Vasc Pharmacol Asunto de la revista: ANGIOLOGIA / FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Eslovenia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google